Company news

Hemostemix Inc news in 2023

Hemostemix Inc's news releases, calls and decks from 2023, newest first.

View company

Hemostemix Clarifies its October 3, 2023 News Release

December 29, 2023

Hemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease

October 30, 2023

Hemostemix Announces Amendment of its $2.5 Million 5 Year Convertible Debenture Issued on June 11, 2021, Resulting in an Expected Interest Saving of Approximately $570,000

October 23, 2023

Hemostemix Closed $320,125 Private Placement

October 3, 2023

Hemostemix Announces New Publication: How NCP-01 Supports Brain Computer Interfaces

September 12, 2023

Hemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant Applications

August 29, 2023

Hemostemix Announces Arbitration Award of CAD $315,684 Plus Private Placement

August 14, 2023

Hemostemix Submits Its Retrospective Heart Study to Leading Stem Cell Journal and Has Prepared Its CLI Phase II Clinical Trial Manuscript for Peer Review

August 8, 2023

Hemostemix Closes $403,539 of the Unit Private Placement

June 28, 2023

Hemostemix's Private Placement Use of Proceeds

June 21, 2023

Hemostemix Announces Unit Private Placement

June 1, 2023

Hemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant Company

May 2, 2023

Hemostemix' Second Round Interviews with Executive Vice President Business Development Candidates

April 3, 2023

Hemostemix Engages Montreal's RobboDesign to SEO Its Website to Engage with 236 Million Peripheral Arterial Disease and Critical Limb Ischemia Patients Globally

March 29, 2023

Hemostemix Closes $762,400 of The Unit Private Placement

March 21, 2023

Hemostemix Unit Offering Repriced

March 8, 2023

Hemostemix Offers up to 500 6% Convertible Debentures, Convertible into an ACP-01 Therapeutic Production Slot that is Subject to Compassionate Exemption from Regulatory Approval

March 7, 2023

The Force Family Office Engaged by Hemostemix

January 31, 2023

Hemostemix' "Your Fountain of Youth" Trademark Granted by Switzerland

January 30, 2023

Hemostemix' "Your Fountain of Youth" Trademark Granted by Japan Patent Office

January 26, 2023

Hemostemix Wins Arbitration Decision

January 24, 2023

Hemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund Up To 75% of 5-Year Costs

January 23, 2023

Hemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre Foundation

January 19, 2023

Decks in 2023